Dr Reddy`s Lab to buy UCB India |
Dr Reddy`s Laboratories, India`s second largest drug maker by sales, on April 1 said it is entering into a definitive agreement to acquire a select portfolio of Belgium-based pharmaceutical firm UCB in India for Rs 800 crore.UCB, listed on Euronext Brussels, has operations in nearly 40 countries with revenues of Euro 3.3 billion (about Rs 22,275 crore) in 2014. The Hyderabad-headquartered drug maker said the established products business of UCB would cover the territories of India, Nepal, Sri Lanka and Maldives, and the acquisition is on a slump sale basis.
|
|
|
|